There is copious literature on addiction, stroke, epilepsy, degenerative disorders (Alzheimer's disease, Parkinson's disease, and ALS, for example), brain trauma, neuropathic pain, schizophrenia, anxiety, and depression, seemingly diverse disease processes of the central nervous system that appear to be associated with the "glutamate cascade."

In May, 1998 a conference was hosted by the National Institutes of Health as a vehicle through which researchers might share what they knew about the relevance of glutamic acid to these various disease processes. (National Institutes of Health, The Glutamate Cascade; Common Pathways of Central Nervous System Disease States. Conference. Bethesda, Maryland, May 3-5, 1998)

In typical FDA, EPA, USDA fashion -- representing the interests of the glutamate industry -- the NIH refused to consider discussing the role processed free glutamic acid (MSG) in causing or exacerbating these disease processes.

+To access information about the conference:

Go to: http://www.nida.nih.gov
Under "Information for Researchers and Health Professionals" click on "Meetings"
The page will be titled "What's New."  On the right is a box that says "What's New Contents"  Click on "Past Meeting Summaries"
Click on "1998"
Scroll down to "The Glutamate Cascade: Common Pathways of Central Nervous System Disease States - Program Book - May 3-5, 1998."
Click on "[Program Book]"

adandjack@aol.com 858/481-9333 http://www.truthinlabeling.org

This page was last updated on June 5, 2004.